C12N 2760/18541
Use of virus, viral particle or viral elements as a vector
C12N2760/18541 (Use of virus, viral particle or viral elements as a vector) appears on 34 US grants and 57 published applications in this corpus.
Search patents in C12N- Granted patents
- 34
- Published applications
- 57
- Assignees
- 35
- Inventors
- 119
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 4 |
| 2004 | 6 | 3 |
| 2005 | 2 | 8 |
| 2006 | 1 | 5 |
| 2007 | 1 | 3 |
| 2008 | 2 | 1 |
| 2009 | 2 | 3 |
| 2010 | 7 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 1 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 3 |
| 2020 | 1 | 1 |
| 2021 | 0 | 3 |
| 2022 | 1 | 2 |
| 2023 | 0 | 2 |
| 2024 | 1 | 4 |
| 2025 | 0 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2760/18543Viral genome or elements thereof as genetic vectorIndexing code32
- C12N 2760/18545Special targeting system for viral vectorsIndexing code2
- C12N 2760/18544Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
- C12N 2760/18542Virus or viral particle as vehicleIndexing code0
Recent patents
- Chimeric RSV and HMPV F proteins, immunogenic compositions, and methods of use10 Feb 2026US 12,544,436 B2Children's Healthcare of Atlanta, Inc.
- Chimeric vectors27 Aug 2024US 12,071,632 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Recombinant RSV antigens, nucleic acid molecules encoding the antigens, and vaccine compositions comprising the same11 Oct 2022US 11,464,850 B2National Taiwan University
- Respiratory syncytial virus expression vectors21 Apr 2020US 10,626,378 B2Children's Healthcare of Atlanta, Inc.
- Respiratory syncytial virus expression vectors12 Mar 2019US 10,227,569 B2Children's Healthcare of Atlanta, Inc.
- Modified Viral Genome Compositions and Methods of Production and Use Thereof4 Jun 2026US 2026/0152727 A1The Board of Regents for the Oklahoma Agricultural and Mechanical Colleges
- Mutant of rsv f protein30 Apr 2026US 2026/0117202 A1National Vaccine and Serum Institute(Nvsi)
- Pan-pneumovirus vaccine compositions and methods of use thereof22 May 2025US 2025/0161429 A1University of Georgia Research Foundation, Inc.
- Chimeric vectors28 Nov 2024US 2024/0392317 A1The United States of America, as represented by the Secretary, Department of Health and Human Servic
- Compositions and methods of ribonucleic acid respiratory syncytial virus (rsv) vaccines7 Nov 2024US 2024/0370011 A1RNAimmune, Inc.
Most cited
By later US patents
- Prevention and treatment of respiratory tract disease115US 5,716,821 AThe UAB Research Foundation · 1998
- Stranded RNA virus particles108US 5,789,229 AThe UAB Research Foundation · 1998
- Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins51US 6,790,449 B2The United States of America as represented by the Department of Health and Human Services · 2004
- Product of infectious respiratory syncytial virus from cloned nucleotide sequences37US 6,264,957 B1The United States of America as represented by the Department of Health and Human Services · 2001
- Attenuated chimeric respiratory syncytial virus31US 7,846,455 B2The United States of America as represented by the Department of Health and Human Services · 2010